UK Markets closed

Genomic Vision Société Anonyme (0QT4.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.0820-0.0057 (-6.50%)
At close: 04:19PM GMT
Full screen
Previous close0.0877
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0000 - 0.0000
52-week range
Volume142,509
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)-0.06
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Genomic Vision and Cambridge Consultants, Part of Capgemini, Announce the Development of an Innovative Technology Platform for In-depth Genomic Analysis

    BAGNEUX, France & CAMBRIDGE, England, November 07, 2022--Regulatory News: Genomic Vision (FR0011799907 – GV, – the "Company") (Paris:GV), a Euronext-listed biotechnology company developing tools and services for the highly accurate characterization of DNA sequences, is pleased to announce the selection of Cambridge Consutants, a world-leading product development and technology consultancy, part of Capgemini Invent1, to jointly develop the next generation of a technology platform for the analysis

  • Business Wire

    Genomic Vision: Financial Information for the Third Quarter of 2022

    BAGNEUX, France, October 27, 2022--Regulatory News: Genomic Vision (FR0011799907 – GV, – the "Company") (Paris:GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announced its revenue and cash position for the nine-month ended on September 30, 2022.

  • Business Wire

    Genomic Vision: Press Release Regarding Changes in the Company’s Governance

    BAGNEUX, France, October 24, 2022--Regulatory News: GENOMIC VISION (FR0011799907 – GV – the "Company") (Paris:GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announced changes in its governance structure following the Company’s ordinary general meeting held on July 11, 2022 (the "General Meeting") and the Company’s Supervisory Board meeting held on July 21, 2022 (the "Supervisory Board meeting").